ASBP
Financials
- Market Capitalization 7.8 M
- Employee N/A
- Founded 2021
- CEO N/A
- Website www.aspirebiolabs.com
- Headquarter Cayman Islands
- FIGI BBG015STV133
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4863 |  RNAZ TransCode Therapeutics, Inc. - Common Stock | 8.50 USD | +1.92% | +4.17% | +64.09% | -10.60% | 8.08 M USD | ||
| 4870 |  ELOX Eloxx Pharmaceuticals, Inc. | 11.40 USD | +0.44% | +2.61% | -23.23% | +14.00% | 7.85 M USD | ||
| 4886 |  BOLT Bolt Biotherapeutics, Inc. - Common Stock | 3.84 USD | +1.59% | -4.48% | -18.99% | -35.46% | 7.38 M USD | ||
| 4887 |  AEON AEON Biopharma, Inc. Class A Common Stock | 0.30 USD | -6.25% | -57.75% | -56.52% | -71.15% | 7.89 M USD |
Frequently asked questions about Aspire Biopharma Holdings, Inc. - Common Stock
What is the Aspire Biopharma Holdings, Inc. - Common Stock stock price today?
The current price of Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) is 6.02. Over the past 24 hours, the stock has changed by +0.84%. Follow the ASBP chart for real-time price dynamics.
What is the stock ticker of Aspire Biopharma Holdings, Inc. - Common Stock?
Aspire Biopharma Holdings, Inc. - Common Stock trades under the ticker ASBP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Aspire Biopharma Holdings, Inc. - Common Stock stock going up?
ASBP has changed by +7.69% over the last week, +19.44% over the last month, and +285.90% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does Aspire Biopharma Holdings, Inc. - Common Stock release financial reports?
Yes. You can track Aspire Biopharma Holdings, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was Aspire Biopharma Holdings, Inc. - Common Stock net income for the last quarter?
Aspire Biopharma Holdings, Inc. - Common Stock reported net income of -3.22 M for the last quarter. The previous quarter showed -4.71 M, which means net income changed by +31.54%.
What is Aspire Biopharma Holdings, Inc. - Common Stock EBITDA?
Aspire Biopharma Holdings, Inc. - Common Stock EBITDA is -62.28 K, and its EBITDA margin is -219.66%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Aspire Biopharma Holdings, Inc. - Common Stock stock?
You can buy Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Aspire Biopharma Holdings, Inc. - Common Stock stock?
Investing in Aspire Biopharma Holdings, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ASBP chart and related analysis on metatrader.com as part of your research.